Kwangdong Phar (009290) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.015x

Based on the latest financial reports, Kwangdong Phar (009290) has a cash flow conversion efficiency ratio of -0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-10.75 Billion ≈ $-7.29 Million USD) by net assets (₩712.31 Billion ≈ $482.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Kwangdong Phar market capitalisation for the company's overall valuation and market capitalisation.

Kwangdong Phar - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kwangdong Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kwangdong Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kwangdong Phar ranked by their cash flow conversion efficiency. Explore 009290 cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Utah Medical Products Inc
NASDAQ:UTMD
0.026x
Hudson Technologies Inc
NASDAQ:HDSN
0.028x
Rhom Bho Property Public Company Limited
BK:TITLE
-0.254x
Shin Yang Shipping Corporation Bhd
KLSE:5173
0.009x
ST George Mining Ltd
AU:SGQ
-0.089x
Kaltura Inc
NASDAQ:KLTR
-1.154x
BAJEL PROJECTS LTD
NSE:BAJEL
0.009x
Shenzhen Dvision Video Communica
SHE:300167
-0.220x

Annual Cash Flow Conversion Efficiency for Kwangdong Phar (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kwangdong Phar from 2011 to 2025. View Kwangdong Phar stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩711.80 Billion
≈ $482.37 Million
₩82.34 Billion
≈ $55.80 Million
0.116x +688.50%
2024-12-31 ₩618.27 Billion
≈ $418.99 Million
₩-12.15 Billion
≈ $-8.24 Million
-0.020x +1.46%
2023-12-31 ₩588.05 Billion
≈ $398.51 Million
₩-11.73 Billion
≈ $-7.95 Million
-0.020x -117.37%
2022-12-31 ₩547.05 Billion
≈ $370.73 Million
₩62.82 Billion
≈ $42.57 Million
0.115x +10.21%
2021-12-31 ₩527.24 Billion
≈ $357.31 Million
₩54.94 Billion
≈ $37.23 Million
0.104x +129.22%
2020-12-31 ₩502.18 Billion
≈ $340.32 Million
₩22.83 Billion
≈ $15.47 Million
0.045x -30.54%
2019-12-31 ₩447.46 Billion
≈ $303.24 Million
₩29.29 Billion
≈ $19.85 Million
0.065x -46.89%
2018-12-31 ₩430.84 Billion
≈ $291.97 Million
₩53.10 Billion
≈ $35.98 Million
0.123x +118.65%
2017-12-31 ₩416.30 Billion
≈ $282.12 Million
₩23.46 Billion
≈ $15.90 Million
0.056x -21.78%
2016-12-31 ₩399.68 Billion
≈ $270.86 Million
₩28.80 Billion
≈ $19.52 Million
0.072x -33.84%
2015-12-31 ₩377.73 Billion
≈ $255.98 Million
₩41.14 Billion
≈ $27.88 Million
0.109x +4.55%
2014-12-31 ₩314.40 Billion
≈ $213.06 Million
₩32.75 Billion
≈ $22.19 Million
0.104x -11.92%
2013-12-31 ₩290.82 Billion
≈ $197.09 Million
₩34.39 Billion
≈ $23.31 Million
0.118x +33.16%
2012-12-31 ₩267.27 Billion
≈ $181.13 Million
₩23.74 Billion
≈ $16.09 Million
0.089x -19.93%
2011-12-31 ₩249.52 Billion
≈ $169.09 Million
₩27.68 Billion
≈ $18.76 Million
0.111x --

About Kwangdong Phar

KO:009290 Korea Packaged Foods
Market Cap
$216.74 Million
₩319.82 Billion KRW
Market Cap Rank
#16338 Global
#595 in Korea
Share Price
₩6440.00
Change (1 day)
+1.42%
52-Week Range
₩5270.00 - ₩11080.00
All Time High
₩11611.32
About

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more